Clinical Trial Update: Single Dose of Tranexamic Acid and Blood Loss, in Elderly Patients With Hip Fracture [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study evaluating a single dose of tranexamic acid to reduce blood loss in elderly patients with hip fractures. The current s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hip Fracture

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: National and Kapodistrian University of Athens | Conditions: Blood Loss, Surgical, Hip Fractures | Phase 2 | Status: UNKNOWN